Product Images Rayos

This is a chart indicating the percentage of ACR20 responders in two different groups: one group with 231 individuals receiving Rayos and DMARD, and the other group with 119 individuals receiving only placebo and DMARD. The chart includes numbers ranging from 4 to 12 on the horizontal axis. No further information is available from this text.*

This is a description of a medication called RAYOS. It is in tablet form, and each tablet contains 1 mg of delayed-release prednisone. The dosage and administration information can be found on the package insert or by consulting a healthcare professional. The medication should be stored at 25°C with permitted excursions. The tablets should be swallowed whole and not crushed, divided, or chewed. No other information is available due to the nature of the text.*

RAYDS® RAYODS® are delayed-release tablets of prednisone typically prescribed for treating inflammation, arthritis, lymphoma, and other conditions. The packaging shows instructions for administration, dosage, and storage, warning that one should swallow the tablet whole without chewing or crushing it. The tablets come in a container with 30 tablets per pack with the stock NDC is 75987-021.01 NDG 7587-021.01.*

RAYDS® (Prednisone) Delayed-release Tablets are a medication used for various inflammatory and autoimmune conditions. They are manufactured in China and come in 5mg and 30mg tablets. The package insert should be consulted for full prescribing information. The tablets should not be crushed or chewed and should be swallowed whole. The drug should be stored at room temperature. The provided text also contains a few illegible characters and a reference to an apparent product code.*